The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

The new prices for the drugs included in the ... because the program doesn’t cover its primary use as an anti-obesity drug. In addition, analysts say that Novo already offers hefty rebates ...

Expanding coverage of anti-obesity drugs could enable more Americans to afford the new weight-loss medications. However, inclusion does not solve access or out-of-pocket costs issues for ...